Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions Ajay Nehra, MD

Slides:

Advertisements

Similar presentations

Figure 1. Forest plot presenting the weighted mean difference on the IIEF erectile function domain final score of trials comparing sildenafil versus placebo.

Advertisements

Malignant Hypertension as a Presenting Symptom of Takayasu Arteritis Talya Wolak, MD, Gabriel Szendro, MD, Luis Golcman, MD, Esther Paran, MD Mayo Clinic.

Clinical Pharmacology, Uses, and Adverse Reactions of Iodinated Contrast Agents: A Primer for the Non-radiologist Jeffrey J. Pasternak, MD, Eric E. Williamson,

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:

Charles D. Burger, MD, Roger K. Resar, MD Mayo Clinic Proceedings

Pleomorphic Adenoma in the Parotid Gland

Managing Cancer Pain: Basic Principles and Invasive Treatments

Ductal Carcinoma in Situ of the Breast

J. Eric Ahlskog, PhD, MD Mayo Clinic Proceedings

Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double- Blind Study in Men With Diabetes Mellitus Irwin Goldstein, MD,

Evaluation of Proteinuria

Erectile Dysfunction and Cardiovascular Disease

William L. Lanier, MD Mayo Clinic Proceedings

Diagnosis and Management of Chronic Kidney Disease

Shireen Mirza, MBBS, Roberto Benzo, MD Mayo Clinic Proceedings

Mucinous Neoplasm of the Appendix and Pseudomyxoma Peritonei

Charles D. Burger, MD, Roger K. Resar, MD Mayo Clinic Proceedings

Review of Childhood Obesity

Management of Adult Onset Seizures

Recognition and Management of Nonrelaxing Pelvic Floor Dysfunction

Peripheral Arterial Disease: Diagnosis and Management

George Dailey, MD Mayo Clinic Proceedings

Understanding Palliative Care and Hospice

Volume 55, Issue 2, Pages (February 2009)

Gestational Trophoblastic Disease

Julia A. Files, MD, Marcia G. Ko, MD, Sandhya Pruthi, MD

Palliative Care and Hospice Programs

Sister Mary Joseph’s Nodule

Cannabinoid Hyperemesis: A Case Series of 98 Patients

Topical Analgesics in the Management of Acute and Chronic Pain

Acupuncture Mayo Clinic Proceedings

Evaluation and Management of Childhood and Adolescent Obesity

Pancreatic Ductal Adenocarcinoma

Troponin T as a Predictor of End-Stage Renal Disease and All-Cause Death in African Americans and Whites From Hypertensive Families LaTonya J. Hickson,

The Red Scalp Sign Mayo Clinic Proceedings

Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline J. Taylor Hays, MD, Jon O. Ebbert,

Refurbishing Mayo Clinic Proceedings:

Antidepressants and Brain Neurochemistry

Gastric Signet Ring Cell Carcinoma

Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,

Cardiovascular Disease in Type 2 Diabetes: A Review of Sex-Related Differences in Predisposition and Prevention Abdallah Al-Salameh, MD, Philippe Chanson,

Classic Hodgkin Lymphoma

Management of Adult Onset Seizures

Pleomorphic Adenoma in the Parotid Gland

Complex Regional Pain Syndrome

Renal Pyelocalyceal Squamous Cell Carcinoma

Evaluation and Management of Penicillin Allergy

Kenneth N. Huynh, BS, Ba D. Nguyen, MD Mayo Clinic Proceedings

Institutional Review Boards: What Clinician Researchers Need to Know

Diabetic Mastopathy Mayo Clinic Proceedings

Hepatocellular Carcinoma

Methylphenidate: Its Pharmacology and Uses

Postoperative Trouble

Pulmonary Tumor Embolism of Unknown Origin

Serial Measurement of Serum Tryptase in Angiotensin-Converting Enzyme Inhibitor- Associated Angioedema Kevin R. Regner, MD, Douglas L. Riegert-Johnson,

Medical Treatment of Overactive Bladder: In Response

Evaluation and Medical Management of Erectile Dysfunction

Dementia and Cerebrovascular Disease

Mantle Cell Involvement of the Spleen

Squamous Cell Carcinoma of the Tongue

Preoperative Smoking Cessation: The Role of the Primary Care Provider

Pink Manta by Joseph Pagano

Medical Student Distress: Causes, Consequences, and Proposed Solutions

Constrictive Pericarditis Due to Graft-vs-Host Disease

Clomiphene-Induced Severe Hypertriglyceridemia and Pancreatitis

Managing Cancer Pain: Basic Principles and Invasive Treatments

The Obesity Paradox: Perception vs Knowledge

Evaluation and Medical Management of Erectile Dysfunction

Diagnosis and Management of Headache in Older Adults

Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”

Presentation transcript:

Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions Ajay Nehra, MD Mayo Clinic Proceedings Volume 84, Issue 2, Pages 139-148 (February 2009) DOI: 10.4065/84.2.139 Copyright © 2009 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE Erectile function and return to normal rates after PDE5 inhibitor use in men with erectile dysfunction and hypertension (top), erectile dysfunction and diabetes (middle), and hyperlipidemia/dyslipidemia (bottom). Numbers inside bars represent medication doses in milligrams. B = baseline; CG = comorbid group; IIEF = International Index of Erectile Function; P = placebo; PDE5 = phosphodiesterase type 5; RG = reference group; S = sildenafil; T = tadalafil; V = vardenafil. Mayo Clinic Proceedings 2009 84, 139-148DOI: (10.4065/84.2.139) Copyright © 2009 Mayo Foundation for Medical Education and Research Terms and Conditions